Your search returned 12 results.

Results
	1.	Intensifying Treatment Beyond Monotherapy in Type 2 Diabetes Mellitus: Where Do Newer Therapies Fit?. [Review] MedStar authors: Aroda, Vanita R Ghazi, Adline Kuhn, Alexander Park, Jean PMID: 28251513 Year: 2017 Citation: Current Cardiology Reports. 19(3):25, 2017 Mar Institution: MedStar Health Research Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Aroda VR, Ghazi A, Kuhn A, Park J DOI: https://dx.doi.org/10.1007/s11886-017-0832-3 Add to cart (remove)
	2.	Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. MedStar authors: Aroda, Vanita R PMID: 26900641 Year: 2016 Citation: Journal of Clinical Endocrinology & Metabolism. 101(4):1754-61, 2016 Apr Institution: MedStar Health Research Institute Medline publication type: Journal Article Multicenter Study Randomized Controlled Trial Form of publication: Journal Article All authors: Aroda VR, Bray GA, Crandall JP, Diabetes Prevention Program Research Group, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, Schade DS, Temprosa MG, White NH DOI: https://dx.doi.org/10.1210/jc.2015-3754 Add to cart (remove)
	3.	Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial. MedStar authors: Garcia-Garcia, Hector M PMID: 36747244 Year: 2023 Citation: Cardiovascular Diabetology. 22(1):28, 2023 02 06. Institution: MedStar Heart & Vascular Institute Medline publication type: Clinical Trial Journal Article Multicenter Study Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Chiarito M, Sanz-Sanchez J, Piccolo R, Condello F, Liccardo G, Maurina M, Avvedimento M, Regazzoli D, Pagnotta P, Garcia-Garcia HM, Mehran R, Federici M, Condorelli G, Diez Gil JL, Reimers B, Ferrante G, Stefanini G DOI: https://dx.doi.org/10.1186/s12933-023-01744-4 Add to cart (remove)
	4.	Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial. MedStar authors: Aroda, Vanita R PMID: 28344112 Year: 2017 Citation: The Lancet Diabetes & Endocrinology. 5(5):355-366, 2017 May Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Axelsen M, Bain SC, Cariou B, DeVries JH, Piletic M, Rose L, Rowe E DOI: https://dx.doi.org/10.1016/S2213-8587(17)30085-2 Add to cart (remove)
	5.	Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW. MedStar authors: Ratner, Robert E PMID: 26982008 Year: 2016 Citation: Journal of Clinical Endocrinology & Metabolism. 101(5):2056-62, 2016 May Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Reaven PD, Schwenke DC, Stentz FB, Tripathy D DOI: https://dx.doi.org/10.1210/jc.2015-4202 Add to cart (remove)
	6.	The utility of metformin therapy in reproductive-aged women with polycystic ovary syndrome (PCOS). [Review] MedStar authors: Nathan, Nisha Sullivan, Shannon D PMID: 24720592 Citation: Current Pharmaceutical Biotechnology. 15(1):70-83, 2014. Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Nathan N, Sullivan SD Add to cart (remove)
	7.	Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study).[Erratum appears in Diabetes Obes Metab. 2016 Sep;18(9):952; PMID: 27546838] MedStar authors: Aroda, Vanita R PMID: 26990378 Year: 2016 Citation: Diabetes, Obesity & Metabolism. 18(7):663-70, 2016 Jul Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Andersen TH, Aroda VR, Bailey TS, Cariou B, Kumar S, Leiter LA, Philis-Tsimikas A, Raskin P, Zacho J DOI: https://dx.doi.org/10.1111/dom.12661 Add to cart (remove)
	8.	Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis. [Review] MedStar authors: Ansari, Amir Mehdi Matsangos, Aerielle E PMID: 28935176 Year: 2017 Citation: Pathology, Research & Practice. 213(10):1237-1241, 2017 Oct. Institution: MedStar Union Memorial Hospital Department: Internal Medicine Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Ansari AM, Li QK, Matsangos AE, Osmani L DOI: https://dx.doi.org/10.1016/j.prp.2017.08.013 Add to cart (remove)
	9.	Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial. MedStar authors: Aroda, Vanita R PMID: 29246950 Year: 2018 Citation: Diabetes Care. 41(2):258-266, 2018 02. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Ahmann AJ, Annett MP, Aroda VR, Capehorn M, Charpentier G, Dotta F, Henkel E, Holst AG, Lingvay I DOI: https://dx.doi.org/10.2337/dc17-0417 Add to cart (remove)
	10.	Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. MedStar authors: Aroda, Vanita R PMID: 32139384 Year: 2020 Citation: Diabetes Care. 43(5):940-947, 2020 05. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Butera NM, Camp AW, Cherrington A, Craig J, Fortmann SP, GRADE Research Group, Hollander PA, Krakoff J, Perez M, Phillips LS, Rasouli N, Sivitz WI, Tan MH, Tiktin M, Wexler DJ, Younes N DOI: https://dx.doi.org/10.2337/dc19-1769 Add to cart (remove)
	11.	Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History). MedStar authors: Ratner, Robert E PMID: 21359834 Year: 2012 Citation: The International Journal of Cardiovascular Imaging. 28(3):455-65, 2012 Mar. Institution: MedStar Health Research Institute Medline publication type: Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: APPROACH study group, Brugaletta S, Garcia-Garcia HM, Garg S, Huang C, Kolatkar NS, Kravitz BG, Miller DM, Morocutti G, Nesto RW, Ratner RE, Serruys PW DOI: http://dx.doi.org/10.1007/s10554-011-9836-z Add to cart (remove)
	12.	A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data. MedStar authors: Aroda, Vanita R PMID: 28939018 Year: 2017 Citation: Journal of Diabetes & its Complications. 31(12):1719-1727, 2017 Dec. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Gourgari E, Hassanzadeh H, Shoulson I, Wilhelm EE DOI: https://dx.doi.org/10.1016/j.jdiacomp.2017.08.005 Add to cart (remove)

Powered by Koha